The Fellow Eye Is Never Just a Bystander
-
By
-
Hashem Abu Serhan
-
June 29, 2026
-
5 min
By
Hashem Abu Serhan
June 29, 2026
A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.
July 8, 2026
Justin Schweitzer, OD, FAAO, and Jessica Steen, OD, FAAO, describe emerging technologies, treatment strategies, and clinical considerations that can help eyecare professionals (ECPs) identify glaucoma earlier and better manage progression.
June 17, 2026